KATIE BROSHUIS: Open Payments
NPI 1437533130 · WEST DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$687 in 34 payments from 12 companies in 2025. Trend: 2023 $797 · 2024 $276 · 2025 $687
Food & beverage: $687
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $152 |
| Lilly USA, LLC | 5 | $117 |
| Regeneron Healthcare Solutions, Inc. | 4 | $95 |
| GENZYME CORPORATION | 3 | $70 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $53 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| UCB, Inc. | 2 | $40 |
| Janssen Biotech, Inc. | 2 | $36 |
| Botanix SB Inc | 1 | $22 |
| Arcutis Biotherapeutics, Inc. | 1 | $20 |
Products named: DUPIXENT, SKYRIZI, EBGLYSS, RINVOQ, Bimzelx, TALTZ, TREMFYA, ILUMYA.
Industry payments across IA — which companies pay providers there.
